Cargando…
Efficacy and safety of Shenmayizhi decoction as an adjuvant treatment for vascular dementia: Study protocol for a randomized controlled trial
BACKGROUND: Vascular dementia (VaD) is the second most common cause of dementia. The treatment of VaD still remains a challenge so far. Traditional Chinese Herbal medicine is a promising therapy due to their multiple components and targets. Shenmayizhi decoction (SMYZD), a Chinese Herbal prescriptio...
Autores principales: | Wang, Huichan, Liu, Nanyang, Wei, Yun, Pei, Hui, Liu, Meixia, Diao, XueMei, Zhang, Huiqin, Li, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6922576/ https://www.ncbi.nlm.nih.gov/pubmed/31852125 http://dx.doi.org/10.1097/MD.0000000000018326 |
Ejemplares similares
-
Shenmayizhi Formula Combined with Ginkgo Extract Tablets for the Treatment of Vascular Dementia: A Randomized, Double-Blind, Controlled Trial
por: Zhang, Huiqin, et al.
Publicado: (2020) -
Probiotics, prebiotics, and synbiotics for the treatment of dementia: Protocol for a systematic review
por: Li, Wenyuan, et al.
Publicado: (2020) -
Traditional Chinese Medicine Shenmayizhi Decoction Ameliorates Memory and Cognitive Impairment Induced by Multiple Cerebral Infarctions
por: Sun, Chengcheng, et al.
Publicado: (2021) -
Efficacy of pharmacotherapy and non-pharmacotherapy of Alzheimer dementia: A protocol for systematic review and meta-analysis
por: Boongird, Chitima, et al.
Publicado: (2022) -
Efficacy and safety of dapagliflozin in the treatment of chronic heart failure: A protocol for systematic review and meta-analysis
por: Dong, Xueyan, et al.
Publicado: (2021)